Apao•AAO Joint Congress, Bali 2009 May 16 -19, 2009.
dc.contributor.author | Satriah, Ismail | |
dc.date.accessioned | 2022-09-13T07:55:41Z | |
dc.date.available | 2022-09-13T07:55:41Z | |
dc.date.issued | 2009 | |
dc.description.abstract | To report our experience in a patient with severe vernal shield ulcer treated with a combination of surgical debridement of the ulcer, supratarsal injection of triamcinolone acetonide, topical cyclosporine 0.05% and ketotifen fumerate 0.025%. Method: A patient with severe, resistant shield ulcer who did not res-pond to medical treatment with topical steroids, mast cell stabilizers and antihistamines was treated with surgical debridement of the ulcer, supratarsal injection of tria111Cinolone acetonide, topical cyclosporine 0.05% and ketetifen fumarate 0.025%. Results: The ulcer healed. well after three weeks. Topical cyclosporine was discontinued after two months. The patient was symptom free with no recurrence for six months. Conclusion: Combination of surgical debridemenr· of the ulcer, supratarsal injection of triamc!nolone acetonide, topical cyclosporine 0.05% and ketotifen fumerate 0.025% are effective as the treatment option in managing patient with severe vernal shield ulcer. Chronic use of topical steroid can be avoided. | en_US |
dc.identifier.uri | http://hdl.handle.net/123456789/16063 | |
dc.publisher | Pusat Pengajian Sains Kesihatan | en_US |
dc.subject | Our experience in a patient with severe vernal shield ulcer treated with a combination of surgical debridement of the ulce | en_US |
dc.title | Apao•AAO Joint Congress, Bali 2009 May 16 -19, 2009. | en_US |
dc.type | Other | en_US |
Files
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: